Efficacy and safety of glecaprevir/pibrentasvir in patients with HCV genotype 5/6: An integrated analysis of phase 2/3 studies

BACKGROUND & AIMS: Hepatitis C virus (HCV) has high genetic diversity with six major genotypes (GT) GT1‐6 and global distribution. HCV GT5 and 6 are rare with < 10 million people infected worldwide. Data on direct‐acting antiviral use in these rare HCV genotypes are limited. The study aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Betty B., Fredrick, Linda M., Schnell, Gretja, Kowdley, Kris V., Kwo, Paul Y., Poordad, Fred, Nguyen, Kinh, Lee, Samuel S., George, Christophe, Wong, Florence, Gane, Edward, Abergel, Armand, Spearman, Catherine W., Nguyen, Tuan, Hung Le, Manh, Pham, Thuy TT., Mensa, Federico, Asselah, Tarik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Viral Hepatitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539968/
https://www.ncbi.nlm.nih.gov/pubmed/32445613
http://dx.doi.org/10.1111/liv.14535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539968/
https://www.ncbi.nlm.nih.gov/pubmed/32445613
http://dx.doi.org/10.1111/liv.14535

Ejemplares similares